Adlai Nortye (NASDAQ:ANL) Research Coverage Started at Leerink Partners

Leerink Partners began coverage on shares of Adlai Nortye (NASDAQ:ANL) in a report released on Friday, Marketbeat reports. The firm issued an outperform rating and a $23.00 target price on the stock.

ANL has been the subject of a number of other research reports. HC Wainwright raised shares of Adlai Nortye from a “neutral” rating to a “buy” rating and set a $16.00 price target for the company in a research report on Friday, February 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Wednesday, January 21st. Finally, Wall Street Zen raised shares of Adlai Nortye to a “hold” rating in a report on Saturday, March 7th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Adlai Nortye presently has a consensus rating of “Hold” and a consensus target price of $19.50.

Adlai Nortye Stock Performance

ANL stock opened at $7.40 on Friday. The stock’s 50 day moving average is $7.25 and its two-hundred day moving average is $3.56. Adlai Nortye has a 52-week low of $0.88 and a 52-week high of $12.09.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.